Efficacy Between Sacubitril/Valsartan versus olmesartan in Patients with Essential Hypertension: Systematic Review

被引：0
|
作者：
Nathania, Florean [1 ]
Sabran, Mohammad Z. [1 ]
Zebua, A. [1 ]
Harjanto, Jovanda A. [1 ]
Rubismo, Kenza Y. [1 ]
Kurniawan, Andree [2 ]
机构：
[1] Pelita Harapan Univ, Fac Med, Tangerang, Banten, Indonesia
[2] Pelita Harapan Univ, Fac Med, Dept Internal Med, Tangerang, Banten, Indonesia
来源：
JOURNAL OF HYPERTENSION | 2024年 / 42卷 / SUPPL 2期
关键词：
Sacubitril; valsartan; Olmesartan; Essential hypertension;
D O I：
10.1097/01.hjh.0001026924.77868.1f
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
36
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Different Doses of Sacubitril/Valsartan Compared with Olmesartan in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis
    Amjaad Ibrahim Almarjan
    Sara Abdulaziz Almarjan
    Ahmed Taher Masoud
    High Blood Pressure & Cardiovascular Prevention, 2023, 30 : 207 - 218
  • [2] Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study
    Hiromi Rakugi
    Kazuomi Kario
    Masako Yamaguchi
    Takayoshi Sasajima
    Hiromi Gotou
    Jack Zhang
    Hypertension Research, 2022, 45 : 824 - 833
  • [3] Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study
    Rakugi, Hiromi
    Kario, Kazuomi
    Yamaguchi, Masako
    Sasajima, Takayoshi
    Gotou, Hiromi
    Zhang, Jack
    HYPERTENSION RESEARCH, 2022, 45 (05) : 824 - 833
  • [4] Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study
    Rakugi, Hiromi
    Kario, Kazuomi
    Yamaguchi, Masako
    Sasajima, Takayoshi
    Gotou, Hiromi
    Zhang, Jack
    HYPERTENSION RESEARCH, 2022,
  • [5] Correction to: Different Doses of Sacubitril/Valsartan Compared with Olmesartan in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis
    Amjaad Ibrahim Almarjan
    Sara Abdulaziz Almarjan
    Ahmed Taher Masoud
    High Blood Pressure & Cardiovascular Prevention, 2023, 30 : 385 - 385
  • [6] Different Doses of Sacubitril/Valsartan Compared with Olmesartan in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis (vol 30, pg 207, 2023)
    Almarjan, Amjaad Ibrahim
    Almarjan, Sara Abdulaziz
    Masoud, Ahmed Taher
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2023, 30 (04) : 385 - 385
  • [7] Efficacy of Sacubitril/Valsartan in Hypertension
    Malik, Aaqib H.
    Aronow, Wilbert S.
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (03) : E322 - E333
  • [8] Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study
    Cheung, Deanna G.
    Aizenberg, Diego
    Gorbunov, Vladimir
    Hafeez, Kudsia
    Chen, Chien-Wei
    Zhang, Jack
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (01): : 150 - 158
  • [9] Different Doses of Scubitril/Valsartan Compared with Olmesartan in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis
    Almarjan, Amjaad Ibrahim
    Almarjan, Sara Abdulaziz
    Masoud, Ahmed Taher
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2023, 30 (03) : 207 - 218
  • [10] Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double-blind, 8-week study
    Huo, Yong
    Li, Weimin
    Webb, Randy
    Zhao, Li
    Wang, Qian
    Guo, Weinong
    JOURNAL OF CLINICAL HYPERTENSION, 2019, 21 (01): : 67 - 76
12345